L. Tzouvelekis

发表

VIM-12, a Novel Plasmid-Mediated Metallo-β-Lactamase from Klebsiella pneumoniae That Resembles a VIM-1/VIM-2 Hybrid

A. Maniatis, S. Pournaras, A. Tsakris, 2005, Antimicrobial Agents and Chemotherapy.

Spread of Integron-Associated VIM-Type Metallo-β-Lactamase Genes among Imipenem-Nonsusceptible Pseudomonas aeruginosa Strains in Greek Hospitals

G. Petrikkos, A. Vatopoulos, L. Tzouvelekis, 2003, Journal of Clinical Microbiology.

Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2)

M. Gazouli, V. Miriagou, L. Tzouvelekis, 1996, Antimicrobial agents and chemotherapy.

VIM-1 Metallo-β-lactamase in Acinetobacter baumannii

A. Maniatis, S. Pournaras, A. Tsakris, 2006, Emerging infectious diseases.

Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011.

E. Petinaki, V. Miriagou, A. Karagouni, 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10).

Michalis Polemis, V. Miriagou, A. Vatopoulos, 2011, The Journal of antimicrobial chemotherapy.

Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting

V. Miriagou, G. Daikos, V. Sypsa, 2020, Antimicrobial Resistance & Infection Control.

Treating infections caused by carbapenemase-producing Enterobacteriaceae.

G. Daikos, M. Souli, A. Markogiannakis, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae

V. Miriagou, S. Kotsakis, A. Vatopoulos, 2013, Journal of chemotherapy.

Confronting carbapenemase-producing Klebsiella pneumoniae.

G. Daikos, L. Tzouvelekis, M. Psichogiou, 2013, Future microbiology.

Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals.

A. Vatopoulos, L. Tzouvelekis, O. Pappa, 2012, International journal of antimicrobial agents.

Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases

V. Miriagou, A. Vatopoulos, L. Tzouvelekis, 2009, Antimicrobial Agents and Chemotherapy.

The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2.

V. Miriagou, M. Tsakiri, G. Daikos, 2010, International journal of antimicrobial agents.

Emergence of Proteus mirabilis carrying the blaVIM‐1 metallo‐β‐lactamase gene

A. Vatopoulos, L. Tzouvelekis, M. Polemis, 2006 .

Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.

V. Miriagou, A. Vatopoulos, L. Tzouvelekis, 2004, FEMS microbiology letters.

Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella.

V. Miriagou, L. Tzouvelekis, N. Legakis, 2004, International journal of antimicrobial agents.

Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum beta-lactamase (IBC-1).

D. Sofianou, L. Tzouvelekis, E. Tzelepi, 2003, International journal of antimicrobial agents.

Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals.

A. Vatopoulos, L. Tzouvelekis, N. Legakis, 2003, International journal of antimicrobial agents.

Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.

A. Philippon, A. Vatopoulos, L. Tzouvelekis, 1990, The Journal of antimicrobial chemotherapy.

Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant

M. Gazouli, V. Miriagou, L. Tzouvelekis, 1997, Antimicrobial agents and chemotherapy.

Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: report of the first three cases.

M. Gazouli, A. Markogiannakis, L. Tzouvelekis, 1998, The Journal of antimicrobial chemotherapy.

Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTX-M-4.

M. Gazouli, L. Tzouvelekis, N. Legakis, 1998, FEMS microbiology letters.

Two novel plasmid-mediated cefotaxime-hydrolyzing beta-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium.

M. Gazouli, A. Markogiannakis, L. Tzouvelekis, 1998, FEMS microbiology letters.

A plasmid-mediated beta-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia.

M. Gazouli, S. Sidorenko, D. Gladin, 1998, The Journal of antimicrobial chemotherapy.

Sequence of the Gene Encoding a Plasmid-Mediated Cefotaxime-Hydrolyzing Class A β-Lactamase (CTX-M-4): Involvement of Serine 237 in Cephalosporin Hydrolysis

M. Gazouli, S. Sidorenko, L. Tzouvelekis, 1998, Antimicrobial Agents and Chemotherapy.

SHV-type beta-lactamases.

R. Bonomo, L. Tzouvelekis, 1999, Current pharmaceutical design.

Emergence of CTX-M-15-Producing Enterobacteria in Cameroon and Characterization of a blaCTX-M-15-Carrying Element

V. Miriagou, P. Ngassam, L. Tzouvelekis, 2005, Antimicrobial Agents and Chemotherapy.

CMY-13, a Novel Inducible Cephalosporinase Encoded by an Escherichia coli Plasmid

V. Miriagou, A. Carattoli, L. Villa, 2004, Antimicrobial Agents and Chemotherapy.

Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.

A. Mentis, A. Tsakris, L. Tzouvelekis, 1993, The Journal of antimicrobial chemotherapy.

Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.

V. Miriagou, R. Bonomo, A. Hujer, 2001, FEMS microbiology letters.

Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.

M. Gazouli, A. Vatopoulos, L. Tzouvelekis, 1998, The Journal of antimicrobial chemotherapy.

Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece.

S. Pournaras, A. Tsakris, L. Tzouvelekis, 2000, The Journal of antimicrobial chemotherapy.

Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4.

E. Petinaki, M. Maniati, A. Maniatis, 2003, The Journal of antimicrobial chemotherapy.

VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Strains in Greek Hospitals

V. Miriagou, S. Kontou, A. Vatopoulos, 2003, Journal of Clinical Microbiology.

Molecular typing of multidrug-resistant Salmonella Blockley outbreak isolates from Greece.

J. Kourea-Kremastinou, L. Tzouvelekis, N. Legakis, 2000, Emerging infectious diseases.

Characterization of Neisseria gonorrhoeae Strains with Decreased Susceptibility to Fluoroquinolones Isolated in Greece from 1996 to 1999

L. Tzouvelekis, E. Tzelepi, A. Mavroidi, 2000, Journal of Clinical Microbiology.

In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.

A. Tsakris, L. Tzouvelekis, N. Legakis, 2010, Diagnostic microbiology and infectious disease.

Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece.

L. Tzouvelekis, E. Tzelepi, A. Mavroidi, 1999, The Journal of antimicrobial chemotherapy.

Sequence of pR3521, an IncB Plasmid from Escherichia coli Encoding ACC-4, SCO-1, and TEM-1 β-Lactamases

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2010, Antimicrobial Agents and Chemotherapy.

Helicobacter pylori infection in spouses of patients with duodenal ulcers and comparison of ribosomal RNA gene patterns.

A. Mentis, N. Skandalis, L. Tzouvelekis, 1996, Gut.

Epidemiology of Metalloenzyme-Producing Pseudomonas aeruginosa in a Tertiary Hospital in Greece

C. Hadjichristodoulou, G. Petrikkos, G. Daikos, 2008, Journal of chemotherapy.

Repeated Occurrence of Diverse Extended-Spectrum β-Lactamases in Minor Serotypes of Food-Borne Salmonella enterica subsp. enterica

A. Vatopoulos, L. Tzouvelekis, N. Legakis, 2005, Journal of Clinical Microbiology.

Current characteristics of male gonorrhoea outpatients in Athens, Greece

L. Tzouvelekis, E. Tzelepi, K. Kyriakis, 2002 .

Prevalence and characterization of class 1 integrons in Escherichia coli of poultry and human origin.

E. Roma, G. Petrikkos, G. Daikos, 2009, Foodborne pathogens and disease.

Multidrug-Resistant Strains of Neisseria gonorrhoeae in Greece

L. Tzouvelekis, E. Tzelepi, A. Mavroidi, 2001, Antimicrobial Agents and Chemotherapy.

Antimicrobial Susceptibility and Types of Neisseria gonorrhoeae in Greece: Data for the Period 1990 to 1993

L. Tzouvelekis, E. Tzelepi, K. Kyriakis, 1997, Sexually transmitted diseases.

Spread of the Streptococcus pneumoniae Taiwan19F-14 clone among children in Greece.

L. Tzouvelekis, T. Athanasiou, A. Mavroidi, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evaluation of the performance of Acuitas® ResistomeTest and the Acuitas Lighthouse® Software for the detection of β-lactamase producing microorganisms.

V. Miriagou, L. Tzouvelekis, E. Tzelepi, 2020, Journal of global antimicrobial resistance.

Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria.

Y. Carmeli, M. Akova, G. Daikos, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

In vitro binding of Helicobacter pylori to human gastric mucin

A. Mentis, L. Tzouvelekis, C. Blackwell, 1991, Infection and immunity.

Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.

V. Miriagou, A. Carattoli, A. Vatopoulos, 2006, The Journal of antimicrobial chemotherapy.

An integron-associated β-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum β-lactamase IBC-1

V. Miriagou, A. Tsakris, D. Sofianou, 2001 .

An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.

V. Miriagou, A. Tsakris, D. Sofianou, 2001, The Journal of antimicrobial chemotherapy.

Genetic variation of coxsackie virus B5 strains associated with aseptic meningitis in Greece

A. Vatopoulos, L. Tzouvelekis, M. Polemis, 2014 .

Diversity of resistance phenotypes and plasmid analysis in multi-resistant 0:12 Pseudomonas aeruginosa

A. Tsakris, A. Vatopoulos, L. Tzouvelekis, 1992, European Journal of Epidemiology.

Relationship of antibiotic resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.

L. Tzouvelekis, N. Legakis, H. Tumah, 1989, Journal of chemotherapy.

CMY-31 and CMY-36 Cephalosporinases Encoded by ColE1-Like Plasmids

V. Miriagou, S. Kotsakis, J. Whichard, 2008, Antimicrobial Agents and Chemotherapy.

GES-13, a β-Lactamase Variant Possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2010, Antimicrobial Agents and Chemotherapy.

KPC-Producing, Multidrug-Resistant Klebsiella pneumoniae Sequence Type 258 as a Typical Opportunistic Pathogen

V. Miriagou, S. Kotsakis, G. Daikos, 2013, Antimicrobial Agents and Chemotherapy.

Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.

M. Kaufmann, A. Mentis, L. Tzouvelekis, 1994, Journal of medical microbiology.

Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impaired permeability.

A. Mentis, A. Vatopoulos, A. Tsakris, 1992, FEMS microbiology letters.

Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections

C. Bamia, G. Petrikkos, G. Daikos, 2009, Antimicrobial Agents and Chemotherapy.

Epidemiologic aspects of male gonococcal infection in Greece.

L. Tzouvelekis, E. Tzelepi, K. Kyriakis, 1999, Sexually transmitted diseases.

mutations leading to the emergence in vivo resistance in a clinical strain of Enterobacter

M. Kaufmann, A. Mentis, L. Tzouvelekis, 1994 .

Consecutive of imipenem mutations leading to the emergence in vivo resistance in a clinical strain of Enterobacter aerogenes

É., A. Mentis, M., 2022 .

Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

S. Liatis, G. Daikos, G. Bamias, 2010, The Journal of antimicrobial chemotherapy.

Supplementation of Growth Media with Zn2+ Facilitates Detection of VIM-2-Producing Pseudomonas aeruginosa

A. Vatopoulos, V. Kalapothaki, L. Tzouvelekis, 2008, Journal of Clinical Microbiology.

Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.

G. Daikos, L. Tzouvelekis, E. Platsouka, 2007, The Journal of antimicrobial chemotherapy.

Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

V. Miriagou, G. Daikos, L. Tzouvelekis, 2007, International journal of antimicrobial agents.

Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model.

V. Miriagou, G. Daikos, L. Tzouvelekis, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Novel Variant (blaVIM-4) of the Metallo-β-Lactamase Gene blaVIM-1 in a Clinical Strain of Pseudomonas aeruginosa

M. Maniati, A. Maniatis, S. Pournaras, 2002, Antimicrobial Agents and Chemotherapy.

Direct Colorimetry of Imipenem Decomposition as a Novel Cost-Effective Method for Detecting Carbapenemase-Producing Enterobacteria

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2022, Microbiology spectrum.

Direct colorimetry of imipenem decomposition as a novel cost effective method for detecting carabapenamase producing bacteria

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2022, bioRxiv.

Characterization of In111, a class 1 integron that carries the extended-spectrum beta-lactamase gene blaIBC-1.

V. Miriagou, L. Tzouvelekis, N. Legakis, 2003, FEMS microbiology letters.

Imipenem Resistance in a Salmonella Clinical Strain Due to Plasmid-Mediated Class A Carbapenemase KPC-2

V. Miriagou, J. Whichard, F. Angulo, 2003, Antimicrobial Agents and Chemotherapy.

Diversity of aminoglycoside resistance inEnterobacter cloacae in Greece

T. Pitt, M. Nikolopoulou, A. Tsakris, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Prevalent mechanisms of resistance among common enterobacterial isolates in Greek hospitals.

A. Maniatis, L. Tzouvelekis, N. Legakis, 1995, Microbial drug resistance.

High prevalence of stably derepressed class-I beta-lactamase expression in multiresistant clinical isolates of Enterobacter cloacae from Greek hospitals.

A. Mentis, A. Vatopoulos, A. Tsakris, 1992, Journal of medical microbiology.

In vitro comparative assessment of beta-lactamase inhibitors and their penicillin combinations against selected enterobacteria.

M. Gazouli, L. Tzouvelekis, N. Legakis, 1997, International journal of antimicrobial agents.

Chemical Analysis and Antimicrobial Activity of the Resin Ladano, of its Essential Oil and of the Isolated Compounds**

M. Gazouli, C. Demetzos, L S Tzouvelekis, 1999, Planta medica.

Spread of a Salmonella typhimurium Clone Resistant to Expanded-Spectrum Cephalosporins in Three European Countries

M. Gazouli, S. Sidorenko, L. Tzouvelekis, 1999, Journal of Clinical Microbiology.

Transferable DHA-1 cephalosporinase in Escherichia coli.

J. Škrlin, A. Vatopoulos, L. Tzouvelekis, 2006, International journal of antimicrobial agents.

Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

G. Daikos, A. Markogiannakis, L. Tzouvelekis, 2012, Clinical Microbiology Reviews.

Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

V. Miriagou, G. Daikos, V. Sypsa, 2014, Antimicrobial Agents and Chemotherapy.

Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective

G. Daikos, M. Souli, L. Tzouvelekis, 2012, Expert review of anti-infective therapy.

Discrepancies and Interpretation Problems in Susceptibility Testing of VIM-1-Producing Klebsiella pneumoniae Isolates

V. Miriagou, G. Petrikkos, G. Daikos, 2005, Journal of Clinical Microbiology.

Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae

A. Mentis, L. Tzouvelekis, E. Tzelepi, 1994, Antimicrobial Agents and Chemotherapy.

Detection in two hospitals of transferable ceftazidime-avibactam resistance in Klebsiella pneumoniae due to a novel VEB β-lactamase variant with a Lys234Arg substitution, Greece, 2019

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolates.

A. Tsakris, L. Tzouvelekis, J. Douboyas, 1994, The Journal of antimicrobial chemotherapy.

On the incidence of antibiotic resistance among aerobic gram-negative rods isolated in Greek hospitals.

A. Tsakris, A. Vatopoulos, L. Tzouvelekis, 1993, The Journal of hospital infection.

CTX-M-3 β-Lactamase-Producing Escherichia coli from Greece

V. Miriagou, L. Tzouvelekis, N. Legakis, 2002 .

Detection of carbapenemase producing enterobacteria using an ion sensitive field effect transistor sensor

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2021, Scientific Reports.

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment.

V. Miriagou, G. Daikos, L. Tzouvelekis, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Crisis of Global Dimensions and Other Enterobacteriaceae: an Evolving Carbapenemases in Klebsiella pneumoniae

G. Daikos, A. Markogiannakis, L. Tzouvelekis, 2012 .

Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin

L. Tzouvelekis, N. Legakis, H. Kotsifaki, 1989, Antimicrobial Agents and Chemotherapy.

Synthesis, lipophilicity studies and antibacterial properties of some novel quaternary ammonium salts.

A. Tsantili-Kakoulidou, A. Mentis, L. Tzouvelekis, 1994, Chemical & pharmaceutical bulletin.

Extended-Spectrum Properties of CMY-30, a Val211Gly Mutant of CMY-2 Cephalosporinase

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2009, Antimicrobial Agents and Chemotherapy.

IBC-1, a Novel Integron-Associated Class A β-Lactamase with Extended-Spectrum Properties Produced by anEnterobacter cloacae Clinical Strain

A. Tsakris, D. Sofianou, L. Tzouvelekis, 2000, Antimicrobial Agents and Chemotherapy.

Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase.

T. Pitt, A. Vatopoulos, L. Tzouvelekis, 1995, The Journal of hospital infection.

Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be

M. Gazouli, L. Tzouvelekis, N. Legakis, 1997, Antimicrobial agents and chemotherapy.

Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases.

V. Miriagou, D. Karageorgopoulos, G. Daikos, 2012, The Journal of antimicrobial chemotherapy.

Mupirocin resistance in Staphylococcus aureus from Greek hospitals.

N. Maniatis, L. Tzouvelekis, N. Legakis, 2001, International journal of antimicrobial agents.

Methicillin-resistant Staphylococcus aureus in the hospitals of central Greece.

E. Petinaki, F. Kontos, V. Miriagou, 2001, International journal of antimicrobial agents.

Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers.

V. Miriagou, S. Kotsakis, G. Daikos, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes

L. Tzouvelekis, N. Legakis, E. Tzelepi, 2000 .

CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes.

L. Tzouvelekis, N. Legakis, E. Tzelepi, 2000, International journal of antimicrobial agents.

Comparison of Short Versus Prolonged Infusion of Standard Dose of Meropenem Against Carbapenemase-Producing Klebsiella pneumoniae Isolates in Different Patient Groups: A Pharmacokinetic-Pharmacodynamic Approach.

V. Miriagou, S. Kotsakis, G. Daikos, 2016, Journal of pharmaceutical sciences.

High rates of resistance to piperacillin/tazobactam among Escherichia coli and Klebsiella pneumoniae strains isolated in a Greek hospital.

A. Tsakris, L. Tzouvelekis, J. Douboyas, 1997, Diagnostic microbiology and infectious disease.

Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital

M. Gazouli, M. Kaufmann, L. Tzouvelekis, 1997, Journal of clinical microbiology.

Escherichia coli with a Self-Transferable, Multiresistant Plasmid Coding for Metallo-β-Lactamase VIM-1

V. Miriagou, L. Tzouvelekis, E. Tzelepi, 2003, Antimicrobial Agents and Chemotherapy.

Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coli

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2015, Antimicrobial Agents and Chemotherapy.

Effects of the Val211Gly substitution on molecular dynamics of the CMY‐2 cephalosporinase: Implications on hydrolysis of expanded‐spectrum cephalosporins

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2011, Proteins.

Plasmid-Encoded ACC-4, an Extended-Spectrum Cephalosporinase Variant from Escherichia coli

V. Miriagou, L. Tzouvelekis, E. Tzelepi, 2007, Antimicrobial Agents and Chemotherapy.

Expanded-Spectrum Cephalosporin-Resistant Salmonella Strains in Romania

V. Miriagou, L. Tzouvelekis, G. Coman, 2002, Journal of Clinical Microbiology.

Characterization of pKP1780, a novel IncR plasmid from the emerging Klebsiella pneumoniae ST147, encoding the VIM-1 metallo-β-lactamase.

V. Miriagou, A. Vatopoulos, L. Tzouvelekis, 2013, The Journal of antimicrobial chemotherapy.

Diversity of β-lactamases among Klebsiella pneumoniae strains isolated in a university hospital in Greece

A. Tsakris, T. Panagea, L. Tzouvelekis, 2004, European Journal of Epidemiology.

Interactions of Oximino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42

V. Miriagou, E. Caselli, S. Kotsakis, 2012, Antimicrobial Agents and Chemotherapy.

SCO-1, a Novel Plasmid-Mediated Class A β-Lactamase with Carbenicillinase Characteristics from Escherichia coli

V. Miriagou, G. Arlet, L. Tzouvelekis, 2007, Antimicrobial Agents and Chemotherapy.

Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.

V. Miriagou, L. Tzouvelekis, G. Dalekos, 2012, International journal of antimicrobial agents.

Characterization of a novel SHV beta-lactamase variant that resembles the SHV-5 enzyme.

M. Gazouli, A. Mentis, L. Tzouvelekis, 1996, FEMS microbiology letters.

Extended-Spectrum β-Lactamase-Producing Klebsiellapneumoniae in a Neonatal Intensive Care Unit in the High-Prevalence Area of Athens, Greece

L. Tzouvelekis, N. Legakis, P. Tassios, 2002, Journal of Clinical Microbiology.

Sporadic Emergence of Klebsiella pneumoniae Strains Resistant to Cefepime and Cefpirome in Greek Hospitals

M. Gazouli, L. Tzouvelekis, N. Legakis, 1998, Journal of Clinical Microbiology.

Resistance to beta-lactams among blood isolates of Salmonella spp. in European hospitals: results from the SENTRY Antimicrobial Surveillance Program 1997-98.

R. Jones, A. Fluit, L. Tzouvelekis, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The isoelectric focusing patterns of beta-lactamases of Yersinia intermedia isolates from aquatic environments.

A. Tsakris, L. Tzouvelekis, E. Tzelepi, 2000, The Journal of antimicrobial chemotherapy.

P861 ECL-1, a novel plasmid-mediated class A β-lactamase with carbenicillinase characteristics from Escherichia coli

V. Miriagou, G. Arlet, L. Tzouvelekis, 2007 .

NOTES SCO-1, a Novel Plasmid-Mediated Class A (cid:2) -Lactamase with Carbenicillinase Characteristics from Escherichia coli (cid:1)

V. Miriagou, G. Arlet, L. Tzouvelekis, 2007 .

Multidrug and Broad-Spectrum Cephalosporin Resistance among Salmonella enterica Serotype Enteritidis Clinical Isolates in Southern Italy

V. Miriagou, A. Carattoli, L. Villa, 2002, Journal of Clinical Microbiology.

Characterization of pKP1433, a Novel KPC-2-Encoding Plasmid from Klebsiella pneumoniae Sequence Type 340

V. Miriagou, A. Vatopoulos, L. Tzouvelekis, 2013, Antimicrobial Agents and Chemotherapy.

Comparative Biochemical and Computational Study of the Role of Naturally Occurring Mutations at Ambler Positions 104 and 170 in GES β-Lactamases

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2010, Antimicrobial Agents and Chemotherapy.

GES-13, a (cid:1) -Lactamase Variant Possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa (cid:1)

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2010 .

Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.

V. Miriagou, A. Vatopoulos, L. Tzouvelekis, 2004, FEMS microbiology letters.

Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.

L. Tzouvelekis, N. Legakis, E. Tzelepi, 1999, The Journal of antimicrobial chemotherapy.

Dissemination of cephalosporin-resistantSerratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals

A. Mentis, L. Tzouvelekis, E. Tzelepi, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Performance of Methods for Detection of Extended-Spectrum β-Lactamases Applied to Clinical Enterobacterial Strains Producing IBC-Type β-Lactamases

L. Tzouvelekis, N. Legakis, G. Stamos, 2003, Journal of Clinical Microbiology.

Amoxycillin/clavulanate resistance as related to β-lactamase content in Escherichia coli strains from community-acquired urinary tract infections in Greece

A. Maniatis, Y. Tselentis, L. Tzouvelekis, 1998 .

Emergence of Serratia liquefaciens and Klebsiella oxytoca with metallo-beta-lactamase-encoding IncW plasmids: further spread of the blaVIM-1-carrying integron In-e541.

V. Miriagou, E. Piperaki, L. Tzouvelekis, 2008, International journal of antimicrobial agents.

Characterization of Metallo-β-Lactamase VIM-27, an A57S Mutant of VIM-1 Associated with Klebsiella pneumoniae ST147

V. Miriagou, S. Kotsakis, A. Vatopoulos, 2011, Antimicrobial Agents and Chemotherapy.

Diversity of Beta-Lactam Resistance Levels Among Related Klebsiella pneumoniae Strains Isolated in an Intensive Care Unit

V. Miriagou, L. Tzouvelekis, E. Tzelepi, 2000, Journal of chemotherapy.

In vitro Activity of Loracarbef against TEM Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains andIts Interaction with the Enzymes

L. Tzouvelekis, N. Legakis, E. Prinarakis, 1998, Chemotherapy.

beta-lactamase ( LAT-2 ) . characterization of a plasmid-mediated group 1 enterobacteria from Greek hospitals and Transferable cefoxitin resistance in

V. Miriagou, L. Tzouvelekis, E. Prinarakis, 1996 .

In vitro activity of cefpirome against selected clinical enterobacterial isolates with β-lactamase-mediated resistance

A. Mentis, L. Tzouvelekis, N. Legakis, 1995, Infection.

Extended spectrum β-lactamases in salmonella strains isolated in Austria.

L. Tzouvelekis, P. Tassios, W. Thiel, 2000 .

Evidence for chromosomal and plasmid location of CMY-2 cephalosporinase gene in Salmonella serotype Typhimurium.

V. Miriagou, K. Joyce, J. Whichard, 2008, The Journal of antimicrobial chemotherapy.

Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.

D. Panagiotakos, A. Vatopoulos, G. Petrikkos, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Absence of the plasmid-mediated quinolone resistance qnrA gene among Campylobacter jejuni clinical isolates from Greece.

A. Vatopoulos, L. Tzouvelekis, S. Chatzipanagiotou, 2005, International Journal of Antimicrobial Agents.

Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases.

V. Miriagou, A. Vatopoulos, L. Tzouvelekis, 2010, International journal of antimicrobial agents.

Relative Strengths of the Class 1 Integron Promoter Hybrid 2 and the Combinations of Strong and Hybrid 1 with an Active P2 Promoter

V. Miriagou, L. Tzouvelekis, C. Papagiannitsis, 2008, Antimicrobial Agents and Chemotherapy.

Ointments containing Ceratothoa oestroides extract: Evaluation of their healing potential in the treatment of diabetic foot ulcers

V. Miriagou, V. Roussis, C. Manes, 2020, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa.

M. Maniati, A. Maniatis, S. Pournaras, 2002, Antimicrobial agents and chemotherapy.

Enhanced in-vitro activity of liposome-trapped penicillin-G against Pseudomonas aeruginosa.

A. Vatopoulos, L. Tzouvelekis, N. Legakis, 1990, Journal of chemotherapy.

Sequence of pNL194, a 79.3-Kilobase IncN Plasmid Carrying the blaVIM-1 Metallo-β-Lactamase Gene in Klebsiella pneumoniae

V. Miriagou, S. Kotsakis, L. Tzouvelekis, 2010, Antimicrobial Agents and Chemotherapy.

Detecting VIM-1 Production in Proteus mirabilis by an Imipenem-Dipicolinic Acid Double Disk Synergy Test

V. Miriagou, J. Casals, L. Tzouvelekis, 2009, Journal of Clinical Microbiology.

Characterization of a Transmissible Plasmid Encoding VEB-1 and VIM-1 in Proteus mirabilis

V. Miriagou, S. Kotsakis, A. Vatopoulos, 2012, Antimicrobial Agents and Chemotherapy.

Providencia stuartii with VIM-1 metallo-β-lactamase

V. Miriagou, M. Tsakiri, L. Tzouvelekis, 2007 .

IS26-Associated In4-Type Integrons Forming Multiresistance Loci in Enterobacterial Plasmids

V. Miriagou, A. Carattoli, L. Villa, 2005, Antimicrobial Agents and Chemotherapy.

SHV-Type β-Lactamases

R. Bonomo, L. Tzouvelekis, 1999, Current pharmaceutical design.

Outbreak of Acinetobacter baumannii with Chromosomally Encoded VIM-1 Undetectable by Imipenem-EDTA Synergy Tests

V. Miriagou, L. Tzouvelekis, E. Tzelepi, 2008, Antimicrobial Agents and Chemotherapy.

Panresistance in VIM-1-producing Klebsiella pneumoniae.

V. Miriagou, G. Daikos, L. Tzouvelekis, 2005, The Journal of antimicrobial chemotherapy.

Pharmacokinetic-pharmacodynamic modelling of meropenem against VIM-producing Klebsiella pneumoniae isolates: clinical implications.

V. Miriagou, S. Kotsakis, G. Daikos, 2016, Journal of medical microbiology.

Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.

L. Tzouvelekis, N. Legakis, D. Kafetzis, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Inhibition of Helicobacter pylori haemagglutination activity by human salivary mucins.

A. Mentis, L. Tzouvelekis, C. Blackwell, 1990, FEMS microbiology immunology.

Klebsiella pneumoniae: Virulence, Biofilm and Antimicrobial Resistance.

G. Daikos, L. Tzouvelekis, G. Syrogiannopoulos, 2017 .

Brief reports Detrimental effect of the combination of R164S with G238S in TEM-1 -lactamase on the extended-spectrum activity conferred by each single mutation

L. Tzouvelekis, N. Legakis, E. Tzelepi, 2000 .

Properties of Mutant SHV-5 β-Lactamases Constructed by Substitution of Isoleucine or Valine for Methionine at Position 69

M. Gazouli, V. Miriagou, L. Tzouvelekis, 1998, Antimicrobial Agents and Chemotherapy.

Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.

L S Tzouvelekis, E Tzelepi, P Giakkoupi, 2000, The Journal of antimicrobial chemotherapy.

Prevalence of a plasmid-mediated type II dihydrofolate reductase gene among trimethoprim-resistant urinary pathogens in Greek hospitals.

T. Pitt, A. Tsakris, A. Johnson, 1992, Journal of Antimicrobial Chemotherapy.

Changes in the rates and population structure of methicillin-resistant Staphylococcus aureus (MRSA) from bloodstream infections: A single-centre experience (2000-2015).

G. Daikos, L. Tzouvelekis, I. Pavlopoulou, 2019, Journal of global antimicrobial resistance.

P993 High prevalence and persistence of the Streptococcus pneumoniae Taiwan19F-14 clone among children in Greece

L. Tzouvelekis, T. Athanasiou, A. Mavroidi, 2007 .

as a Typical Opportunistic Pathogen Klebsiella pneumoniae Sequence Type 258 KPC-Producing, Multidrug-Resistant

V. Miriagou, S. Kotsakis, G. Daikos, 2014 .